Stay updated on Pyrotinib+Capecitabine in Trastuzumab-Resistant Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib+Capecitabine in Trastuzumab-Resistant Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib+Capecitabine in Trastuzumab-Resistant Breast Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A notice says NIH websites are transitioning terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    0.8%
    Check dated 2026-10-23T23:30:49.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-16T23:31:08.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer now displays software revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-09T23:30:45.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    The record history now shows a new revision v3.7.0, replacing the previous v3.6.6, indicating that the study record has been updated.
    Difference
    0.1%
    Check dated 2026-09-18T22:54:22.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    The record history now shows a new revision entry labeled v3.6.6, replacing the earlier v3.6.5. This reflects an update to the study record's version history rather than substantive study data.
    Difference
    0.1%
    Check dated 2026-08-28T18:08:36.000Z thumbnail image
  6. Check
    80 days ago
    Change Detected
    Summary
    The record history now includes a new version entry, Revision: v3.6.5. The previous Revision: v3.6.4 has been removed, reflecting an update to the log rather than study content.
    Difference
    0.1%
    Check dated 2026-08-07T10:20:20.000Z thumbnail image

Stay in the know with updates to Pyrotinib+Capecitabine in Trastuzumab-Resistant Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib+Capecitabine in Trastuzumab-Resistant Breast Cancer Clinical Trial page.